Effect of pertussis vaccination on clinical manifestations of infants and young children with pertussis
TANG Qi-Qin, GAN Chuan, WU Xiao-Ying, XU Hong-Mei, ZHANG Zhen-Zhen
Department of Infection, Children's Hospital, Chongqing Medical University/Ministry of Education Key Laboratory of Child Development and Disorders/National Clinical Research Center for Child Health and Disorders(Chongqing)/China International Science and Technology Cooperation Base of Child Development and Critical Disorders/Chongqing Key Laboratory of Pediatrics, Chongqing 400014, China
Abstract Objective To study the effect of pertussis vaccination on the clinical manifestations of infants and young children with pertussis. Methods A retrospective analysis was performed to investigate the differences in clinical manifestations and peripheral blood cell levels between pertussis children with different pertussis vaccination status. Results A total of 1 083 children with pertussisat at age of <3 years were enrolled, with 551 children in the unvaccinated group and 532 in the vaccinated group. Of all the children, 392 had an age of onset of < 3 months (372 were unvaccinated and 20 were vaccinated) and 691 children had an age of onset of ≥ 3 months (179 were unvaccinated and 512 were vaccinated). Compared with the vaccinated group, the unvaccinated group had a longer length of hospital stay and a higher incidence rate of respiratory failure (P < 0.05). Among the children ≥ 3 months of age, the incidence of severe pneumonia in the unvaccinated group was higher than that in the vaccinated group (P < 0.05), and the incidence of severe pneumonia was the highest in the unvaccinated group (10.6%) and the lowest in the 4-dose vaccination group (1.2%). Among the 101 patients with severe pneumonia, 80 (79.2%) were observed in the unvaccinated group and only 21 (20.8%) in the four different doses vaccination groups. For the children with an age of onset of ≥ 3 months, the unvaccinated group had higher white blood cell count, absolute value of lymphocytes, and platelet count than the vaccinated group (P < 0.05). Conclusions Pertussis vaccination can reduce the incidence of severe pneumonia and respiratory failure and alleviate the severity of respiratory complications in infants and young children with pertussis.
TANG Qi-Qin,GAN Chuan,WU Xiao-Ying et al. Effect of pertussis vaccination on clinical manifestations of infants and young children with pertussis[J]. CJCP, 2021, 23(2): 138-142.
TANG Qi-Qin,GAN Chuan,WU Xiao-Ying et al. Effect of pertussis vaccination on clinical manifestations of infants and young children with pertussis[J]. CJCP, 2021, 23(2): 138-142.
Klein NP, Bartlett J, Rowhani-Rahbar A, et al. Waning protection after fifth dose of acellular pertussis vaccine in children[J]. N Engl J Med, 2012, 367(11):1012-1019.
[11]
Barlow RS, Reynolds LE, Cieslak PR, et al. Vaccinated children and adolescents with pertussis infections experience reduced illness severity and duration, Oregon, 2010-2012[J]. Clin Infect Dis, 2014, 58(11):1523-1529.
[12]
Murray EL, Nieves D, Bradley JS, et al. Characteristics of severe Bordetella pertussis infection among infants ≤ 90 days of age admitted to pediatric intensive care units-Southern California, September 2009-June 2011[J]. J Pediatric Infect Dis Soc, 2013, 2(1):1-6.
[13]
Ganeshalingham A, Mcsharry B, Anderson B, et al. Identifying children at risk of malignant Bordetella pertussis infection[J]. Pediatr Crit Care Med, 2017, 18(1):e42-e47.
